Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (1,318) Arrow Down
Filter Results: (1,318) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,318)
    • People  (2)
    • News  (339)
    • Research  (765)
    • Events  (2)
    • Multimedia  (5)
  • Faculty Publications  (389)

Show Results For

  • All HBS Web  (1,318)
    • People  (2)
    • News  (339)
    • Research  (765)
    • Events  (2)
    • Multimedia  (5)
  • Faculty Publications  (389)
← Page 6 of 1,318 Results →
  • 31 Oct 2013
  • News

Have corporate and government leaders lost accountability?

  • 26 Mar 2020
  • News

Coronavirus Is Widening the Corporate Digital Divide

  • 18 Sep 2014
  • News

The shortcomings of the corporate wellness program

  • 01 Feb 1997
  • News

Ban the Butterfly Rule for Corporate Directors

You're only as good as your job title? Apparently so, if you're the director of a major company. A corporate governance precept currently in vogue calls for outside directors to offer to resign if they change (or lose) their jobs.... View Details
Keywords: Joseph Hinsey IV
  • September 2013 (Revised May 2014)
  • Case

OdontoPrev

By: Regina E. Herzlinger, Matthew Lingenbrink, Joshua Turnbull and Ricardo Reisen De Pinho
Brazil's largest dental insurer, a successful and innovative firm, has saturated the corporate market and faces stiffer competition. It must decide whether to enter a new market in Brazil or to expand into other parts of Central and South America. View Details
Keywords: Health; Business or Company Management; Market Entry and Exit; Insurance; Health Industry; Health Industry; North and Central America; Brazil
Citation
Educators
Purchase
Related
Herzlinger, Regina E., Matthew Lingenbrink, Joshua Turnbull, and Ricardo Reisen De Pinho. "OdontoPrev." Harvard Business School Case 314-038, September 2013. (Revised May 2014.)
  • 14 Oct 2002
  • Research & Ideas

The Widening Rift Between Corporations and Society

Society is evolving and it is leaving business behind, say HBS professor Shoshana Zuboff and James Maxmin. In their new book, The Support Economy: Why Corporations are Failing Individuals and the Next Episode of Capitalism, they address... View Details
Keywords: by Martha Lagace
  • October 2022 (Revised September 2024)
  • Case

mPharma: Scaling Access to Affordable Primary Care in Africa

By: Regina E. Herzlinger and Ben Creo
mPharma hopes to scale up to create the largest pan-African healthcare company ever to provide much-needed primary care in retail pharmacies; a reliable, fairly priced supply of drugs; and micro-insurance for drugs. They must prioritize launching a telemedicine... View Details
Keywords: Africa; Pharmaceutical Companies; Pharmacy Benefit Manager; Health Care; Health Care And Treatment; Health Care Costs; Health Care Delivery; Health Care Entrepreneurship; Telehealth; Health Equity; Corporate Strategy; Social Entrepreneurship; Equity; Growth and Development Strategy; Expansion; Product Launch; Customer Value and Value Chain; Social Enterprise; Multinational Firms and Management; Health Industry; Health Industry; Africa
Citation
Educators
Purchase
Related
Herzlinger, Regina E., and Ben Creo. "mPharma: Scaling Access to Affordable Primary Care in Africa." Harvard Business School Case 323-033, October 2022. (Revised September 2024.)
  • August 2023
  • Case

Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company

By: Satish Tadikonda and Brad Prosek
Constellation Pharmaceuticals was a company focused on epigenetic therapies for cancer patients. Despite a promising start and an early deal with a leading biopharma company, the company weathered twin setbacks in the end of a major research collaboration and the... View Details
Keywords: Mergers and Acquisitions; Health Care and Treatment; Organizational Change and Adaptation; Research and Development; Business Strategy; Partners and Partnerships; Goals and Objectives; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Tadikonda, Satish, and Brad Prosek. "Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company." Harvard Business School Case 824-032, August 2023.
  • Web

Creating Value Through Corporate Restructuring - Course Catalog

debtor-in-possession (DIP) financing, mass tort clais, restructuring of retiree health care/pension plans, and corporate layoff/downsizing programs. While the course focuses on U.S. corporates, it also... View Details
  • May 2012 (Revised August 2014)
  • Case

McKesson

By: Regina E. Herzlinger and Natalie Kindred
McKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010 revenues, just made its first foray into... View Details
Keywords: Health Care Industry; Health Care Policy; Organizational Transformations; Health Services; Health Care and Treatment; Business Model; Service Operations; Change Management; Corporate Strategy; Information Technology; Policy; Health Industry; Health Industry; United States
Citation
Educators
Purchase
Related
Herzlinger, Regina E., and Natalie Kindred. "McKesson." Harvard Business School Case 312-002, May 2012. (Revised August 2014.)
  • Fall 2020
  • Article

Sizing Up Corporate Restructuring in the COVID Crisis

By: Robin Greenwood, Benjamin Iverson and David Thesmar
In the wake of the COVID-19 pandemic, the financial and legal system will need to deal with a surge of financial distress in the business sector. Some firms will be able to survive, while others will face bankruptcy and thus need to be liquidated or reorganized. Many... View Details
Keywords: COVID-19; Health Pandemics; Economy; System Shocks; Financial Crisis; Restructuring
Citation
Read Now
Related
Greenwood, Robin, Benjamin Iverson, and David Thesmar. "Sizing Up Corporate Restructuring in the COVID Crisis." Brookings Papers on Economic Activity (Fall 2020). (Also NBER Working Paper, No. 28104.)
  • August 2008
  • Teaching Note

Go Red for Women: Raising Heart Health Awareness (TN)

By: V. Kasturi Rangan and Marie Madelene Bell
Teaching Note for [507026]. View Details
Keywords: Corporate Strategy; Financing and Loans; Risk and Uncertainty; Advertising Campaigns; Health Care and Treatment; Health Industry
Citation
Purchase
Related
Rangan, V. Kasturi, and Marie Madelene Bell. "Go Red for Women: Raising Heart Health Awareness (TN)." Harvard Business School Teaching Note 509-017, August 2008.
  • June 2024 (Revised December 2024)
  • Case

Lana Ghanem: Pushing the Boundaries of Health Care Through Venture Capital

By: Joshua D. Margolis and Ahmed Dahawy
Lana Ghanem, managing director of Hikma Ventures, the corporate venture arm of larger pharmaceutical group Hikma, is considering how to grow the venture arm as well as progress her own career. Over the past few years Hikma's executive team had been pressuring the... View Details
Keywords: Business Divisions; Corporate Entrepreneurship; Investment; Corporate Governance; Health Care and Treatment; Leadership Development; Business or Company Management; Growth and Development Strategy; Business Strategy; Venture Capital; Personal Development and Career; Health Industry; Health Industry; Jordan
Citation
Educators
Purchase
Related
Margolis, Joshua D., and Ahmed Dahawy. "Lana Ghanem: Pushing the Boundaries of Health Care Through Venture Capital." Harvard Business School Case 424-075, June 2024. (Revised December 2024.)
  • 01 Apr 2020
  • News

Coronavirus Is Putting Corporate Social Responsibility to the Test

  • 06 Aug 2020
  • News

Interview with Professor Regina Herzlinger on Balancing Entrepreneurship and Corporate Governance with a Prominent Academic Career

  • Web

Leadership, Ethics, and Corporate Accountability Course | HBS Online

Pitts VP and Senior Medical Director at St. Joseph Heritage Health Read more learner stories * Source: 2022 surveys and course data All FAQs Leadership, Ethics, and Corporate Accountability FAQs What are the... View Details
  • Web

Women, Work, and the “M” Word - Blog: Health Supplement

their menopausal health and wellness is overlooked by their employer. One in five women report having left or considered leaving a job because of their menopause symptoms. Women are vital to the U.S. workforce, and the Great Resignation... View Details
  • 17 Feb 2016
  • Blog Post

Through The Eyes of The Patient: A Recap of The 13th Annual Health Care Conference

markets, to changing the drug discovery process to be more patient-centric. A highlight of the panel sessions was when Adam Koppel, EVP of Strategy and Corporate Development at Biogen and Health Care... View Details
Keywords: Health Care
  • December 2013 (Revised May 2021)
  • Case

Paul Levy: Confronting a 'Corporate Campaign' (A)

By: James K. Sebenius
Hospital CEO Paul Levy confronts an SEIU unionization drive via a "corporate campaign" aimed at undercutting the hospital's relationships with key internal and external constituencies. Having shepherded one of Boston's top teaching hospitals much of the way through a... View Details
Keywords: Dispute Resolution; Corporate Campaign; Negotiating Campaign; Bargaining; Health Care; Hospitals; Unions; Health Care and Treatment; Negotiation; Strategy; Negotiation Process; Labor Unions; Health Industry; Boston
Citation
Educators
Purchase
Related
Sebenius, James K. "Paul Levy: Confronting a 'Corporate Campaign' (A)." Harvard Business School Case 914-020, December 2013. (Revised May 2021.)
  • March 1999
  • Case

Merck & Co., Inc.: Corporate Strategy, Organization and Culture (A)

By: Michael Beer and Perry Fagan
In the early 1990s, Merck faced a series of challenges because of significant changes in its competitive and regulatory environment (e.g., growth in power of pharmaceutical buyers like managed care organizations led to price pressures and President Clinton's review of... View Details
Keywords: Organizational Change and Adaptation; Business or Company Management; Organizational Culture; Problems and Challenges; Management Practices and Processes; Competitive Strategy; Management Teams; Health Care and Treatment; Governing Rules, Regulations, and Reforms; Situation or Environment; Alignment; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Beer, Michael, and Perry Fagan. "Merck & Co., Inc.: Corporate Strategy, Organization and Culture (A)." Harvard Business School Case 499-054, March 1999.
  • ←
  • 6
  • 7
  • …
  • 65
  • 66
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.